How to prepare a medicine sourcing request
Short answer
A good sourcing request names the medicine by INN and, where needed, brand, with strength, form, pack and quantity. It also states the destination country, consignee type, permit status, minimum shelf life, Incoterm and date needed. With those details an exporter can confirm availability, documents and lead time in one reply instead of several.
Key takeaways
- Name the medicine by its international non-proprietary name, and add the brand and manufacturer whenever the prescriber, protocol or tender requires a specific product.
- State the destination country, the consignee type and the permit status, because they decide which documents and which legal route apply.
- Give the quantity, the minimum remaining shelf life on arrival and the date needed, so the supplier can check batches and lead time together.
- Choose an Incoterm and delivery point early, since the local permit holder usually has to act as importer of record.
- Attach the licence, permit or application and any protocol or tender reference, and keep patient identity data out of the first request.
- Ask for the documents you will need, such as the certificate of analysis and certificate of pharmaceutical product, in the same message.
Most delays in sourcing a specialty or unregistered medicine start with an incomplete request. A message that only names a medicine leaves the exporter to guess the strength, the market version, the destination rules and the timing, and each guess needs another round of email. A complete request lets a supplier in India check availability, batches, documents, shipping and the legal route in one pass.
This guide lists the fields a sourcing request should contain and explains why each one matters. The same fields appear in the quote request form, so it can also be read as a guide to filling that in.
What a complete request contains
| Field | Example | Why it matters |
|---|---|---|
| International non-proprietary name | Pembrolizumab | Identifies the active substance without ambiguity |
| Brand and manufacturer, if required | A named reference brand and its marketing authorisation holder | Needed for biologics, comparators and prescriber-specified products |
| Strength and dosage form | 100 mg/4 mL concentrate for infusion | Different strengths are different products |
| Pack and presentation | Vial, pre-filled syringe or pen, pack of 1 | Presentations differ between markets |
| Quantity | 6 vials | Drives batch allocation, price and packaging |
| Destination country | Kenya | Sets the legal route and document set |
| Consignee type | Hospital pharmacy, licensed importer, CRO, NGO or government buyer | Decides who holds the permit and receives the goods |
| Permit status | Not filed, pending or issued, with number and validity | Tells the exporter which documents to prepare now |
| Minimum remaining shelf life | At least 12 months on arrival | Rules out short-dated batches early |
| Incoterm and delivery point | CIP Nairobi airport | Allocates cost, risk and clearance duties |
| Temperature requirement | 2 to 8°C | Decides packaging and lane |
| Date needed | Delivered by a stated date | Lets the supplier check the lead time is realistic |
The example values are for illustration only and do not describe any real order.
Product identity
Name and brand
WHO describes international non-proprietary names as unique, globally recognised names that belong to the public domain. Using the INN avoids confusion between local brand names, which can differ from one country to the next. Add the brand and the manufacturer when a specific product is required. That is normal for biologics, where EU law expects adverse reaction reports to identify the product by name and batch under Directive 2010/84/EU, and for trial comparators, where the protocol may name one market version. The guide on biosimilars and reference biologics explains why.
Strength, form and pack
Give the strength exactly as prescribed, the dosage form, the pack size and, for injectables, the presentation. A request for a medicine in vials when the prescriber expects a pen will not pass the hospital's check on arrival.
Market of origin and alternatives
Say which market versions are acceptable, for example an EU pack, an Indian pack or any version approved in a named country. If the prescriber, sponsor or tender allows alternatives, list them and attach the decision. If not, say that no substitution is allowed.
Destination, consignee and permit status
The destination country decides the legal route, and the consignee decides who holds the permit. In the United Kingdom, for example, an unlicensed import is notified to MHRA by a licensed wholesaler or specials manufacturer, not by the patient. In Mexico, the COFEPRIS sanitary import permit has separate modalities for institutions, personal use, donations and research. The country import guides set out each route.
State the permit status in one of three ways:
- Not yet filed. The exporter will prepare the proforma invoice and product documents the application needs.
- Pending. Give the filing date and the regulator, so the exporter can hold stock if possible.
- Issued. Give the permit number, the product and quantity it covers and its validity. Mexican permits, for example, are valid for 180 days, and Kazakh conclusions lapse at the end of the calendar year.
Patients and families should route the request through the treating physician or hospital. The first request does not need the patient's name or identity documents. Those are shared later, only as the route requires.
Quantity, shelf life and timing
Quantity, shelf life and date work together. A supplier may hold enough stock across several batches but not in one batch with the shelf life needed. State:
- the total quantity and whether a single batch is required, as trial sponsors may ask
- the minimum remaining shelf life on arrival, as covered in shelf-life requirements in medicine supply
- the date the goods are needed at the destination, not the date the request is sent
For trials, ICH E6(R3) asks sponsors to make sure investigational products are used only within their current shelf life, so the remaining shelf life has to cover the whole dosing period. The lead-time estimator shows whether the date is realistic once permit, export and transit time are added.
Commercial and logistics terms
Incoterm and delivery point
The Incoterms 2020 rules published by the International Chamber of Commerce set out how cost, risk and obligations are split between seller and buyer. For permit-based imports, CIP or DAP to the hospital or its customs broker are common, and FCA suits importers with their own forwarder. DDP is rarely practical when the local permit holder must be importer of record. The Incoterms guide covers each choice.
Temperature and mode
State the labelled storage condition. Room-temperature parcels often go by courier, while cold-chain and larger lots may need air cargo with qualified packaging. The guides on courier versus air cargo and cold-chain shipping of biologics explain the trade-offs, and the cold-chain transit checker tests a lane.
Currency and payment
Say which currency you will pay in and how, for example by bank transfer or letter of credit, and whether payment terms depend on the permit being issued. The options are covered in how to pay for an international medicine order. The landed cost calculator estimates duty and tax at the destination.
Attachments and document requests
Attach what proves the buyer can lawfully receive the goods:
- the consignee's licence, such as a hospital, pharmacy, wholesale or import licence
- the permit, notification or application, where one exists
- the trial protocol reference and sponsor details for comparators
- the tender reference and quality clause for donor-funded supply
In the same message, list the documents you need from the supplier, for example the certificate of analysis, the certificate of pharmaceutical product, the GMP certificate and a proforma invoice in the permit holder's name. The document checklist builds the list for each country, and pharma export documents explained describes each one.
Common gaps that slow a quote
The same omissions come up again and again. Checking for them before sending saves a round of questions:
- Strength without units or volume. For injectables, give both the amount and the volume, for example per vial.
- A brand name only. Local brand names differ between countries, so always add the INN.
- No consignee type. The exporter cannot tell whether a hospital, importer or physician will hold the permit.
- No shelf-life minimum. The first quote may offer a batch that is too short for the treatment or trial.
- No date or an unrealistic date. Permit, export and transit time add up, and the request should say what happens if the date cannot be met.
- Patient identity in the first email. It is not needed to check availability and should be shared only through the proper route.
Step by step: sending the request
- Confirm the product details with the prescriber, sponsor or tender document.
- Check the destination route and the consignee in the country guide.
- Fill in every field in the table above, marking anything not yet known.
- Attach the licence and permit papers, without patient identity data.
- List the documents you need from the supplier.
- Send the request and keep its reference for the permit application.
- When the quote arrives, check that the product, batch, shelf life, Incoterm and lead time match the request before accepting it.
Before trusting any reply, check who is answering. The guide on how to verify a medicine supplier lists the licences and records to ask for.
This page explains how regulatory routes work. It is not legal or medical advice. Confirm current requirements with the regulator or a local agent before goods ship.
Questions and answers
Should I name a brand or only the generic name?
Use the international non-proprietary name in every request. Add the brand and manufacturer when the prescriber, trial protocol or tender requires a specific product, which is usual for biologics and comparators. If other products are acceptable, say so and attach the prescriber's or sponsor's decision.
Can I send a request before the import permit is issued?
Yes. Many permits need a proforma invoice and product documents from the supplier, so the request usually comes first. State that the permit is not yet filed or is pending, and the exporter can prepare the documents the application needs.
Should a patient's name be included in a sourcing request?
Not in the first request. Availability, price and lead time can be confirmed without identity data. Patient details are shared later, only as the destination route requires, usually by the treating physician or hospital and not by the patient directly.
Which Incoterm should I choose?
For permit-based imports CIP or DAP to the hospital or its customs broker are common, and FCA suits importers with their own forwarder. DDP is rarely practical when the local permit holder must be importer of record. The Incoterms guide explains each option.
What shelf life should I ask for?
State the minimum remaining shelf life you need on arrival, based on your usage period and any tender or regulatory rule. Without a stated minimum, the supplier may offer the next available batch, which may not fit a long treatment or trial.
References
- 1.WHO, International Nonproprietary Names (INN)
- 2.International Chamber of Commerce, Incoterms 2020
- 3.GOV.UK, Notification of intent to import an unlicensed medicinal product
- 4.COFEPRIS, Manual for the sanitary import permit for medicines without registration
- 5.ICH E6(R3) Guideline for good clinical practice, Step 4 (6 January 2025)
- 6.Directive 2010/84/EU amending Directive 2001/83/EC as regards pharmacovigilance
Related import guides
Ready to request a medicine?
Tell us what you need and where it goes. The reply sets out availability, the legal route, the documents and a realistic lead time.